|
| |
Cellexus Biosystems plc appoints IUL as its
exclusive distributor in Austria, Benelux Germany, the Netherlands and
Switzerland
26th June 2007
Cellexus Biosystems plc (PLUS Markets: CBIO), the specialist in the design,
manufacture and commercialisation of novel disposable technology for growing
cells, has entered into a distribution agreement with IUL Instruments GmbH, of
Königswinter, Germany.
IUL distributes an extensive range of cell-based reagents and instruments to the
biotechnology and biopharmaceutical industries, covering countries from Austria
to the Netherlands. The Company’s headquarters are located in Germany, with a
wholly owned subsidiary in the Netherlands.
Commenting on the agreement, Dr Kevin Auton, CEO of Cellexus Biosystems, said:
“We were very clear from the outset that our strategy within the European
Economic area required us to partner with organisations that had developed
effective local sales channels. In choosing a partner for this region, we looked
for a company that could provide our customers with the best service and support
available - and this required a localised sales and support infrastructure. IUL
is unusual in that the organisation operates throughout several of the countries
that contain some of the highest densities of biopharmaceutical companies and
research institutes within the European Economic area. This, coupled with
expertise in microbiology and biotechnology, makes IUL an ideal partner in this
region and we look forward to the added momentum that the company will bring to
our expansion.”
Alexander Beljaars, Managing Director of IUL, commented:
“Adding the CellMakerTM product range is an important strategic step for IUL to
take. We have a wide range of products that we supply to our customers for
microbiology and biotechnology and so the CellMaker bioreactors are a natural
extension for us. We have built a very successful business as a distributor for
other companies who manufacture products that are complementary to the CellMaker
product range. We believe that our existing customer base will welcome the
opportunity to invest in the CellMaker products, knowing that they have the
local service and support that my organisation can provide.”
Ends
Further information:
Cellexus Biosystems plc:
Dr Kevin Auton
12 Ramsay Court
Hinchingbrooke Business Park
Huntingdon
Cambridgeshire PE29 6FY
United Kingdom
+44 1480 453 858
kevin.auton@cellexusbiosystems.com
www.cellexusbiosystems.com
IUL Instruments GmbH:
Alex Bejars, Managing Director
Königswinterer Str. 409
53639 Königswinter
+49 2223 91920
info@iul-instruments.de
www.iul-instruments.de
JM Finn & Co, corporate adviser:
Clive Carver
4 Coleman Street,
London
EC2R 5TA
United Kingdom
+44 207 600 1659
clive.carver@jmfinn.com
www.jmfinn.com
Hybridan LLP, Cellexus Biosystems’ broker:
Claire Noyce
Stephen Austin
60 Lombard Street,
London EC3V 9EA
United Kingdom
+44 20 3159 5085
claire.noyce@hybridan.com
www.hybridan.com
Media enquiries:
Capital MS&L, PR advisers for Cellexus Biosystems
Mary Clark/ Peter Curtain
+44 20 7307 5330
peter.curtain@capitalmsl.com
www.captialmsl.com
Trade Press enquiries:
Not This Limited, Marketing advisers for Cellexus Biosystems
Jessica Auton
+44 1480 352 821
jessica.auton@notthislimited.co.uk
www.notthislimited.co.uk
Notes to editors:
Cellexus Biosystems has developed a range of value-added disposables to help
researchers in the biopharmaceutical industry and academia, develop new
biopharmaceutical products from cell lines. Biopharmaceuticals are the new breed
of medicines, generated by culturing cells in bioreactors. These medicines are
often proteins, such as antibodies or can be vaccines. The potential of future
medical treatments offered by stem cell research would also fall within this
category. Sales of biopharmaceuticals reached US$60 billion in 2005 and are
growing at 20% per annum.
The Company has already developed a family of products. Three products have been
developed all based around the core technology - the CellexusBagTM – and are
marketed under the name: CellMaker Lite2TM. These products potentially offer
significant technological improvements for cell culture and cell growth in the
developing disposables market.
Unlike competitive products, the CellexusBag products do not need to be shaken,
rocked or rolled, which means the equipment used to manage the cell culture
process is very simple and inexpensive. Patent application protecting the
Company’s intellectual property was filed in December 2005.
Images of the CellMaker Lite2 can be downloaded from the Company’s website
http://www.cellexusbiosystems.com/index_files/CellexusBiosystemsMediaResources.htm
IUL Instruments GmbH
www.iul-instruments.de
| |
|
